Abstract
The RAG1 endonuclease, together with its cofactor RAG2, is essential for V(D)J recombination but is a potent threat to genome stability. The sources of RAG1 mis-targeting and the mechanisms that have evolved to suppress it are poorly understood. Here, we report that RAG1 associates with chromatin at thousands of active promoters and enhancers in the genome of developing lymphocytes. The mouse and human genomes appear to have responded by reducing the abundance of "cryptic" recombination signals near RAG1 binding sites. This depletion operates specifically on the RSS heptamer, whereas nonamers are enriched at RAG1 binding sites. Reversing this RAG-driven depletion of cleavage sites by insertion of strong recombination signals creates an ectopic hub of RAG-mediated V(D)J recombination and chromosomal translocations. Our findings delineate rules governing RAG binding in the genome, identify areas at risk of RAG-mediated damage, and highlight the evolutionary struggle to accommodate programmed DNA damage in developing lymphocytes.
Original language | English |
---|---|
Pages (from-to) | 751-765 |
Number of pages | 15 |
Journal | Cell |
Volume | 162 |
Issue number | 4 |
DOIs | |
State | Published - 13 Aug 2015 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2015 Elsevier Inc.
Funding
The authors thank S. Zhou for assistance with mice, E. Corbett for antibody production, Y. Zhang and F. Alt for the Atm −/− I-SceI v-abl cell line, J. Henao-Meija for the CRISPR/Cas9 guide RNA sequence for Hprt, and S. Smale and J. Langermann for valuable advice. This work was supported in part by an NIH NRSA Institutional Postdoctoral Training Grant (T32 AI007019) and a Cancer Research Institute Irvington Postdoctoral Fellowship (G.T.), R37 AI32524 (D.G.S.), R01 GM0888847 (M.C.), by the Intramural Research Program of NIAMS, NIH (R.C.), and by a Burroughs Wellcome Fund Career Award (L.G.C.). D.G.S. is an investigator of the Howard Hughes Medical Institute. This study used high-performance computational capabilities of the NIH Biowulf Linux cluster.
Funders | Funder number |
---|---|
Burroughs Wellcome Fund | |
Cancer research institute | |
Howard Hughes Medical Institute | |
NIH NRSA | T32 AI007019 |
National Institutes of Health | |
National Institutes of Health | |
National Cancer Institute | P30CA142543 |
National Institute of Arthritis and Musculoskeletal and Skin Diseases | |
Burroughs Wellcome Fund | |
Cancer research institute | R01 GM0888847, R37 AI32524 |